Clinical relevance of circulating angiogenic cells in patients with ischemic stroke
- PMID: 35313809
- PMCID: PMC8939119
- DOI: 10.1186/s12872-021-02421-8
Clinical relevance of circulating angiogenic cells in patients with ischemic stroke
Abstract
Background: Endothelial progenitor cells (EPCs) are circulating angiogenic cells with endothelial features associated with risk for stroke. We aimed to delve into their functional characteristics. EPCs were isolated and cultured from Ischemic Stroke (IS) patients and predictors of their variance evaluated.
Methods: This is a single-center observational study evaluating 187 consecutively hospitalized patients with IS. EPCs were isolated from blood samples. The number of circulating angiogenic cells (CACs), colony-forming units (CFU-ECs) and the emergence of late outgrowths endothelial cells (LOECs) were counted. We collected clinical variables and measured the stromal cell-derived factor 1 alpha (SDF1α) serum levels. We also examined the relative telomere length and the expression of osteogenic gene markers in CACs.
Results: CACs counts and CFU-ECs colony numbers were positively correlated (rho = 0.41, p < 0.001, n = 187). We found significant differences according to whether thrombolytic treatment was performed in the distribution of CFU-ECs (odds ratio (OR) = 2.5; 95% confidence interval (CI) 1.01-6.35; p = 0.042) and CACs (OR = 4.45; 95% IC 1.2-15.5; p = 0.012). The main determinants of CACs variation were the number of risks factors, thrombolysis treatment, arterial hypertension, LOECs occurrence, and the vascular endothelial growth factor expression, whereas CFU-ECs variations depended on hemoglobin content and the relative reduction in the National Institutes of Health Stroke Scale (NIHSS) criteria. The main predictors of LOECs appearance were thrombolysis and length of hospital stay.
Conclusions: Our study supports the relevance of patient risk factors and treatments in the analysis of the functional properties of EPCs.
Keywords: Biomarkers; Circulating angiogenic cells; Colony forming cells; Endothelial progenitor cells; Functionality; Gene; Ischemic stroke; Late outgrowth endothelial cells.
© 2022. The Author(s).
Conflict of interest statement
Authors declare no competing interests.
Figures



Similar articles
-
Elevated Inflammatory Parameter Levels Negatively Impact Populations of Circulating Stem Cells (CD133+), Early Endothelial Progenitor Cells (CD133+/VEGFR2+), and Fibroblast Growth Factor in Stroke Patients.Curr Neurovasc Res. 2019;16(1):19-26. doi: 10.2174/1567202616666190129164906. Curr Neurovasc Res. 2019. PMID: 30706812
-
Circulating endothelial progenitor cells as a new marker of endothelial dysfunction or repair in acute stroke.Stroke. 2008 May;39(5):1441-7. doi: 10.1161/STROKEAHA.107.499236. Epub 2008 Mar 20. Stroke. 2008. PMID: 18356550
-
Exercise acutely increases circulating endothelial progenitor cells and monocyte-/macrophage-derived angiogenic cells.J Am Coll Cardiol. 2004 Jun 16;43(12):2314-8. doi: 10.1016/j.jacc.2004.02.049. J Am Coll Cardiol. 2004. PMID: 15193699
-
Endothelial progenitor cell subsets and preeclampsia: Findings and controversies.J Chin Med Assoc. 2017 Oct;80(10):615-622. doi: 10.1016/j.jcma.2017.06.013. Epub 2017 Jul 14. J Chin Med Assoc. 2017. PMID: 28716604 Review.
-
Neovascularization and tissue regeneration by endothelial progenitor cells in ischemic stroke.Neurol Sci. 2021 Sep;42(9):3585-3593. doi: 10.1007/s10072-021-05428-3. Epub 2021 Jul 3. Neurol Sci. 2021. PMID: 34216308 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical